NDC 68180-288-06 Abacavir And Lamivudine
Tablet, Film Coated Oral

Package Information

What is NDC 68180-288-06?

The NDC Code 68180-288-06 is assigned to a package of 30 tablet, film coated in 1 bottle of Abacavir And Lamivudine, a human prescription drug labeled by Lupin Pharmaceuticals, Inc.. The product's dosage form is tablet, film coated and is administered via oral form. The following table has all the important details about this NDC code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

Field Name Field Value
NDC Code 68180-288-06
Package Description 30 TABLET, FILM COATED in 1 BOTTLE
Product Code 68180-288
Proprietary Name What is the Proprietary Name?
The proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.		 Abacavir And Lamivudine
Non-Proprietary Name What is the Non-Proprietary Name?
The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.		 Abacavir And Lamivudine
11-Digit NDC Billing Format NDC Format for Billing
For insurance billing purposes the Centers for Medicare & Medicaid Services (CMS) created an 11 digit NDC derivative identifier. If the NDC Package code is less than 11 digits the code must be padded with leading zeros. The leading zeros must be added to the appropriate segment to create a 5-4-2 configuration.		 68180028806
Billing Unit EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Estimated Billable Units per Package 30 EA
NADAC Wholesale Price per Unit National Average Drug Acquisition Cost (NADAC)
The National Average Drug Acquisition Cost (NADAC) wholesale price per unit for NDC 68180-288-06 is $2.57673 and is up-to-date as of 02-01-2023. This product is billed for "EA" each discreet unit and contains an estimated amount of 30 billable units per package. The estimated wholesale price for the this package based on the lastest NADAC pricing survey is $77.30		 $2.57673
Estimated Wholesale Price per Package $77.30
NDC to RxNorm Crosswalk
  • RxCUI: 602393 - abacavir sulfate 600 MG / lamiVUDine 300 MG Oral Tablet
  • RxCUI: 602393 - abacavir 600 MG / lamivudine 300 MG Oral Tablet
  • RxCUI: 602393 - abacavir (as abacavir sulfate) 600 MG / lamivudine 300 MG Oral Tablet
  • RxCUI: 602393 - abacavir 600 MG / 3TC 300 MG Oral Tablet
    • Product Type What kind of product is this?
    Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.    		 Human Prescription Drug
    Labeler Name Lupin Pharmaceuticals, Inc.
    Dosage Form Tablet, Film Coated - A solid dosage form that contains medicinal substances with or without suitable diluents and is coated with a thin layer of a water-insoluble or water-soluble polymer.
    Administration Route(s)
    • Oral - Administration to or by way of the mouth.
    Active Ingredient(s)
    Pharmacologic Class(es)
    Sample Package Sample Package?
    This field Indicates whether this package is a sample packaging or not.    		 No
    Marketing Category What is the Marketing Category?
    Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.    		 ANDA - A product marketed under an approved Abbreviated New Drug Application.
    FDA Application Number What is the FDA Application Number?
    This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.    		 ANDA204990
    Start Marketing Date What is the Start Marketing Date?
    This is the date that the labeler indicates was the start of its marketing of the drug product.    		 03-28-2017
    Listing Expiration Date What is the Listing Expiration Date?
    This is the date when the listing record will expire if not updated or certified by the product labeler.    		 12-31-2023
    Exclude Flag What is the NDC Exclude Flag?
    This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions ("Y"), or because the listing certification is expired ("E"), or because the listing data was inactivated by FDA ("I"). Values = "Y", "N", "E", or "I".     		N
    NDC Code Structure

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Other Product Packages

    The following packages are also available for Abacavir And Lamivudine with product NDC 68180-288.

    NDC Package CodePackage Description
    68180-288-0990 TABLET, FILM COATED in 1 BOTTLE
    68180-288-33750 TABLET, FILM COATED in 1 POUCH

    * Please review the disclaimer below.